Medtronic MiniMed Insulin Pump Recall Over Battery Failure Risks
MiniMed insulin pumps have a history of problems that have led to numerous recalls over the last decade, following reports of over or under delivery of insulin.
MiniMed insulin pumps have a history of problems that have led to numerous recalls over the last decade, following reports of over or under delivery of insulin.
FDA indicates that the batteries in Medtronic video laryngoscopes may overheat or explode, posing a risk of serious injury or death for patients.
Recalled Medtronic MiniMed insulin pumps have been linked to reports of hypoglycemia, hyperglycemia and other serious injuries.
At least 77 complaints have been received involving problems with recalled Medtronic NIM endotracheal tubes, including reports of the devices losing functionality and degrading.
Similar problems have plagued various Medtronic syringe pumps over the last couple years, leading to multiple recalls
Similar software problems resulted in an earlier Medfusion pump recall in 2022, affecting about twice as many units that may pose a risk of serious and life-threatening injuries.
The FDA first warned of problems with Cardinal Health Monoject syringes failing to fit drug pumps in November 2023.
A defective occlusion sensor in the infusion pump battery packs can lead to delays in treatment, which may have contributed to at least one patient death.
The FDA is warning that the devices can shut down unexpectedly, but issued recommendations for their continued use by medical providers
Wrongful death lawsuit alleges that family was informed of a Medtronic MiniMed recall just days after a fatal insulin pump overdose occurred, when one of the pumps malfunctioned.